Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juana A Flores-Le Roux

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|July 22, 2014
[Efficacy studies]Juan Pedro-Botet, Juana A Flores-Le Roux
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|November 5, 2013
[Gestational diabetes mellitus: importance of blood glucose monitoring]Juana A Flores Le-Roux, David Benaiges Boix, Juan Pedro-Botet
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|October 4, 2016
[Map of resources and healthcare needs for patients with dyslipidaemia in Spain: The MADI study]Juan Pedro-Botet, Elisenda Climent, Eva Giralt Martínez, et al.
World Journal of Clinical Cases|September 19, 2014
Subclinical cardiovascular disease in type 2 diabetes mellitus: To screen or not to screenJuan J Chillarón, Juana A Flores-Le Roux, David Benaiges, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|December 15, 2015
[Cardiovascular prevention in diabetes mellitus: A multifactorial challenge]Juan Pedro-Botet, Juan J Chillarón, David Benaiges, et al.
Metabolism: Clinical and Experimental|November 27, 2013
Type 1 diabetes, metabolic syndrome and cardiovascular riskJuan J Chillarón, Juana A Flores Le-Roux, David Benaiges, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|September 23, 2017
Past, present and future of pharmacotherapy for obesityDavid Benaiges, Juan Pedro-Botet, Juana A Flores-Le Roux, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|March 28, 2018
Diabetes mellitus as a protective factor of abdominal aortic aneurysm: Possible mechanismsElisenda Climent, David Benaiges, Juan J Chillarón, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|February 5, 2015
[Dapagliflozin: Beyond glycemic control in the treatment of type 2 diabetes mellitus]Pol Sanz-Serra, Juan Pedro-Botet, Juana A Flores-Le Roux, et al.
Expert Opinion on Drug Safety|September 21, 2016
Severity of statin-induced adverse effects on muscle and associated conditions: data from the DAMA studyJuan Pedro-Botet, Jesús Millán Núñez-Cortés, Juan J Chillarón, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|July 22, 2014
[Efficacy studies]Juan Pedro-Botet, Juana A Flores-Le Roux
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|November 5, 2013
[Gestational diabetes mellitus: importance of blood glucose monitoring]Juana A Flores Le-Roux, David Benaiges Boix, Juan Pedro-Botet
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|October 4, 2016
[Map of resources and healthcare needs for patients with dyslipidaemia in Spain: The MADI study]Juan Pedro-Botet, Elisenda Climent, Eva Giralt Martínez, et al.
World Journal of Clinical Cases|September 19, 2014
Subclinical cardiovascular disease in type 2 diabetes mellitus: To screen or not to screenJuan J Chillarón, Juana A Flores-Le Roux, David Benaiges, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|December 15, 2015
[Cardiovascular prevention in diabetes mellitus: A multifactorial challenge]Juan Pedro-Botet, Juan J Chillarón, David Benaiges, et al.
Metabolism: Clinical and Experimental|November 27, 2013
Type 1 diabetes, metabolic syndrome and cardiovascular riskJuan J Chillarón, Juana A Flores Le-Roux, David Benaiges, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|September 23, 2017
Past, present and future of pharmacotherapy for obesityDavid Benaiges, Juan Pedro-Botet, Juana A Flores-Le Roux, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|March 28, 2018
Diabetes mellitus as a protective factor of abdominal aortic aneurysm: Possible mechanismsElisenda Climent, David Benaiges, Juan J Chillarón, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|February 5, 2015
[Dapagliflozin: Beyond glycemic control in the treatment of type 2 diabetes mellitus]Pol Sanz-Serra, Juan Pedro-Botet, Juana A Flores-Le Roux, et al.
Expert Opinion on Drug Safety|September 21, 2016
Severity of statin-induced adverse effects on muscle and associated conditions: data from the DAMA studyJuan Pedro-Botet, Jesús Millán Núñez-Cortés, Juan J Chillarón, et al.
Pageof 6